GH Research (GHRS) Common Equity (2021 - 2026)
GH Research's Common Equity came in at $359.49 million for Q2 2026, up 18.6% from $303.18 million a year earlier and up 36.5% from the prior quarter.
Powered by 
Analysis
GH Research (GHRS) Common Equity (2021 - 2026) Analysis & Trends
At the end of FY2025, GH Research's Common Equity was $279.7 million, up 56.3% from FY2024.
- Common Equity carries a four-year compound annual growth rate of 0.2% (FY2021 to FY2025).
- Going back by year, Common Equity was $178.95 million in FY2024 (-18.3%), $218.97 million in FY2023 (-12.3%), $249.82 million in FY2022 (-9.9%) and $277.18 million in FY2021.
- The Q2 2026 figure represents the highest quarterly Common Equity in data going back to Q3 2021.
- Year-over-year, Common Equity increased in five of the last eight quarters, with growth averaging 22.5%.
- The fastest year-over-year change in Common Equity over five years came in Q4 2025 (growth of 56.3%), and the weakest in Q4 2024 (a decline of 18.3%).
- Business Quant data shows GHRS's Common Equity at $263.38 million (Q1 2026), $279.7 million (Q4 2025) and $291.4 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | GH Research | 1.45 Bn | 292.39 Mn | - | 359.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 359.49 Mn |
| Mar 31, 2026 | 263.38 Mn |
| Dec 31, 2025 | 279.70 Mn |
| Sep 30, 2025 | 291.40 Mn |
| Jun 30, 2025 | 303.18 Mn |
| Mar 31, 2025 | 310.21 Mn |
| Dec 31, 2024 | 178.95 Mn |
| Sep 30, 2024 | 189.37 Mn |
| Jun 30, 2024 | 198.68 Mn |
| Mar 31, 2024 | 209.75 Mn |
| Dec 31, 2023 | 218.97 Mn |
| Sep 30, 2023 | 225.77 Mn |
| Jun 30, 2023 | 232.98 Mn |
| Mar 31, 2023 | 241.83 Mn |
| Dec 31, 2022 | 249.82 Mn |
| Sep 30, 2022 | 256.74 Mn |
| Jun 30, 2022 | 263.22 Mn |
| Mar 31, 2022 | 269.48 Mn |
| Dec 31, 2021 | 277.18 Mn |
| Sep 30, 2021 | 283.60 Mn |
API Access
GH Research Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=GHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "GHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=GHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();